S
Sonoval is developing novel anticancer therapies targeting lymphomas and solid tumors through dual mechanisms that enhance tumor cell apoptosis and inhibit tumor growth. These therapies aim to improve treatment efficacy and patient outcomes in oncology by addressing the limitations of current cancer treatments.
Updated 20 months ago
Funding
$73.7K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
ONFunding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Sonoval is developing novel anticancer therapies targeting lymphomas and solid tumors through dual mechanisms that enhance tumor cell apoptosis and inhibit tumor growth. These therapies aim to improve treatment efficacy and patient outcomes in oncology by addressing the limitations of current cancer treatments.